Developing new medications to treat alcohol use disorder
Medication Development for the Treatment of Alcohol Use Disorder
This study is looking at a new medication called BEM to see how it works in the body and if it’s safe to use with other drugs, all to help people who are dealing with alcohol use disorder.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Tech University Health Scis Center NIH-funded |
| Lab location | 1 site (Lubbock, United States) |
| Project ID | NIH-11230815 on NIH RePORTER |
What this research studies
This research focuses on creating new medications for alcohol use disorder (AUD), which affects millions of people. The team will conduct a series of studies to understand how a new drug, 10-butyl ether minocycline (BEM), is processed in the body and whether it interacts with other medications. The research includes both laboratory studies and early clinical trials to assess the safety and effectiveness of BEM. By addressing the limitations of existing treatments, this project aims to improve outcomes for individuals struggling with AUD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alcohol use disorder who are seeking new treatment options.
Not a fit: Patients who do not have alcohol use disorder or those who are not currently seeking treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for individuals with alcohol use disorder.
How similar studies have performed: Previous research has shown promise in developing new pharmacotherapies for alcohol use disorder, but this specific approach with BEM is novel.
Where this research is happening
Lubbock, United States
- Texas Tech University Health Scis Center — Lubbock, United States (Active)
Researchers
- Principal investigator: Bergeson, Susan E. — Texas Tech University Health Scis Center
- Study coordinator: Bergeson, Susan E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.